2016年AATS Focus on Thoracic Surgery: Lung and Esophageal Cancer 会议于3月19-20日在上海完美落幕。AME编辑部携旗下JTD, ACS，ATM等相关杂志参加了本次会议，全程报道精彩内容。会上，笔者很荣幸邀请到大会主席之一，David Sugarbaker 教授接受AME专访, 分享他在大会上的精彩报告，并就人工智能、年轻医师培养等几个热点问题提出了他独特的想法。来自美国休斯敦 Baylor College of Medicine的Sugarbaker 教授，是2013-2014年度AATS主席，也是AME旗下Annals of Translational Medicine杂志的作者。
图1. David Sugarbaker 教授作为大会主席之一致辞
Sugarbaker教授是世界上胸膜间皮瘤诊疗的权威学者，是胸膜间皮瘤的三维（tri-modal）治疗方法（手术、放疗、化疗）的主要开拓者和倡导者。关于胸膜间皮瘤的诊疗，Sugarbaker教授于近日撰写了一篇题为“Perspective on malignant pleural mesothelioma diagnosis and treatment”，将于3月底发表在旗下Annals of Translational Medicine杂志。
图2. 胸膜间皮瘤的诊断和治疗 - by Prof. Sugarbaker and Dr. Ori Wald
图3. Sugarbaker教授与采访编辑Jessie Zhong
Q1: There was a lunch symposium discussing the differences of education of young thoracic surgeons between North America, China and Europe. How do you see the differences? How do you think to better educate them?
Q2: You may have heard that recently the computer AlphaGo won in a Go-chess showdown against the world's top player. Some people say artificial intelligence may replace many roles of human in the future, including surgeons. How do you think?
Q3: As one of the co-director of the meeting, would you like to share some highlights with our readers?
Q4: Are there any plans/projects with AATS in near future to share with us?
David J. Sugarbaker, MD.
Professor and Chief,
Division of General Thoracic Surgery,
Michael E. DeBakey Department of General Surgery,
Director, Lung Institute, Baylor College of Medicine,
Olga Keith Wiess Chair in Surgery, Baylor College of Medicine,
Houston, TX, USA.
Prof. David Sugarbaker is a world-renowned doctor and certified thoracic surgeon widely credited for developing the first tri-modal treatment approach for malignant pleural mesothelioma. His current leadership appointments include Professor of Surgery and Chief of General Thoracic Surgery at the Michael E. DeBakey Department of Surgery and Director of the Lung Institute at Baylor College of Medicine. Formerly, Dr. Sugarbaker served as Chief of Thoracic Surgery at Brigham and Women’s Hospital, Chief of Surgical Services at the Dana-Farber Cancer Institute, Executive Vice-Chair of Department of Surgery at Brigham and Women’s Hospital, and Professor of Surgery at Harvard Medical School.